Report Summary
Eternity Insights has published a new study on Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market focusing on key segments as by Type (Drug Eluting Balloons, Normal Balloons, Scoring Balloons, Cutting Balloons), by Application (Hospitals, Clinics, Ambulatory Surgical Centers, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Percutaneous Transluminal Angioplasty (PTA) Balloons Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Percutaneous Transluminal Angioplasty (PTA) Balloons Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Segmentation:
Percutaneous Transluminal Angioplasty (PTA) Balloons Market, By Type
- Drug Eluting Balloons
- Normal Balloons
- Scoring Balloons
- Cutting Balloons
Percutaneous Transluminal Angioplasty (PTA) Balloons Market, By Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Percutaneous Transluminal Angioplasty (PTA) Balloons market in terms of demand generation. The Percutaneous Transluminal Angioplasty (PTA) Balloons market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Percutaneous Transluminal Angioplasty (PTA) Balloons market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Taxonomy:
To learn more about this report
Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Competitive Landscape
The global Percutaneous Transluminal Angioplasty (PTA) Balloons market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- C. R. Bard
- Cook Medical
- Abbott
- Cardinal Health
- Boston Scientific
- Philips
- Medtronic
- SurModics
- Endocor
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Drug Eluting Balloons, Normal Balloons, Scoring Balloons, Cutting Balloons |
| By Application Outlook |
Hospitals, Clinics, Ambulatory Surgical Centers, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
C. R. Bard, Cook Medical, Abbott, Cardinal Health, Boston Scientific, Philips, Medtronic, SurModics, Endocor |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Size Growth Rate by Product
1.4.2 Drug Eluting Balloons
1.4.3 Normal Balloons
1.4.4 Scoring Balloons
1.4.5 Cutting Balloons
1.5 Market by End User
1.5.1 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Size
2.1.1 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue 2014-2025
2.1.2 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Sales 2014-2025
2.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Growth Rate by Regions
2.2.1 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Regions
2.2.2 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Manufacturers
3.1.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Manufacturers
3.1.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Sales Market Share by Manufacturers
3.1.3 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market Concentration Ratio (CR5 and HHI)
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Manufacturers
3.2.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Manufacturers (2017-2020)
3.2.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue Share by Manufacturers (2017-2020)
3.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Price by Manufacturers
3.4 Percutaneous Transluminal Angioplasty (PTA) Balloons Manufacturing Base Distribution, Product Types
3.4.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Percutaneous Transluminal Angioplasty (PTA) Balloons Product Type
3.4.3 Date of International Manufacturers Enter into Percutaneous Transluminal Angioplasty (PTA) Balloons Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Product
4.2 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Product
4.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Breakdown Data by End User
6 North America
6.1 North America Percutaneous Transluminal Angioplasty (PTA) Balloons by Countries
6.1.1 North America Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Countries
6.1.2 North America Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Percutaneous Transluminal Angioplasty (PTA) Balloons by Product
6.3 North America Percutaneous Transluminal Angioplasty (PTA) Balloons by End User
7 Europe
7.1 Europe Percutaneous Transluminal Angioplasty (PTA) Balloons by Countries
7.1.1 Europe Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Countries
7.1.2 Europe Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Percutaneous Transluminal Angioplasty (PTA) Balloons by Product
7.3 Europe Percutaneous Transluminal Angioplasty (PTA) Balloons by End User
8 Asia Pacific
8.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons by Countries
8.1.1 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Countries
8.1.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons by Product
8.3 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons by End User
9 Central & South America
9.1 Central & South America Percutaneous Transluminal Angioplasty (PTA) Balloons by Countries
9.1.1 Central & South America Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Countries
9.1.2 Central & South America Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Percutaneous Transluminal Angioplasty (PTA) Balloons by Product
9.3 Central & South America Percutaneous Transluminal Angioplasty (PTA) Balloons by End User
10 Middle East and Africa
10.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons by Countries
10.1.1 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Sales by Countries
10.1.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons by Product
10.3 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons by End User
11 Company Profiles
11.1 C. R. Bard
11.1.1 C. R. Bard Company Details
11.1.2 Company Business Overview
11.1.3 C. R. Bard Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.1.4 C. R. Bard Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.1.5 C. R. Bard Recent Development
11.2 Cook Medical
11.2.1 Cook Medical Company Details
11.2.2 Company Business Overview
11.2.3 Cook Medical Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Cook Medical Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.2.5 Cook Medical Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Company Business Overview
11.3.3 Abbott Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Abbott Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.3.5 Abbott Recent Development
11.4 Cardinal Health
11.4.1 Cardinal Health Company Details
11.4.2 Company Business Overview
11.4.3 Cardinal Health Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Cardinal Health Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.4.5 Cardinal Health Recent Development
11.5 Boston Scientific
11.5.1 Boston Scientific Company Details
11.5.2 Company Business Overview
11.5.3 Boston Scientific Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Boston Scientific Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.5.5 Boston Scientific Recent Development
11.6 Philips
11.6.1 Philips Company Details
11.6.2 Company Business Overview
11.6.3 Philips Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Philips Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.6.5 Philips Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Company Business Overview
11.7.3 Medtronic Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Medtronic Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.7.5 Medtronic Recent Development
11.8 SurModics
11.8.1 SurModics Company Details
11.8.2 Company Business Overview
11.8.3 SurModics Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.8.4 SurModics Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.8.5 SurModics Recent Development
11.9 Endocor
11.9.1 Endocor Company Details
11.9.2 Company Business Overview
11.9.3 Endocor Percutaneous Transluminal Angioplasty (PTA) Balloons Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Endocor Percutaneous Transluminal Angioplasty (PTA) Balloons Products Offered
11.9.5 Endocor Recent Development
12 Future Forecast
12.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Market Forecast by Regions
12.1.1 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Sales Forecast by Regions 2019-2025
12.1.2 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue Forecast by Regions 2019-2025
12.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Market Forecast by Product
12.2.1 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Sales Forecast by Product 2019-2025
12.2.2 Global Percutaneous Transluminal Angioplasty (PTA) Balloons Revenue Forecast by Product 2019-2025
12.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Market Forecast by End User
12.4 North America Percutaneous Transluminal Angioplasty (PTA) Balloons Forecast
12.5 Europe Percutaneous Transluminal Angioplasty (PTA) Balloons Forecast
12.6 Asia Pacific Percutaneous Transluminal Angioplasty (PTA) Balloons Forecast
12.7 Central & South America Percutaneous Transluminal Angioplasty (PTA) Balloons Forecast
12.8 Middle East and Africa Percutaneous Transluminal Angioplasty (PTA) Balloons Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
